CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 20 enrolled
Drug / intervention
NaF/ KNO3/isopentane Dentifrice +3 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00752089
NCT00752089Phase 2Completed

Exploratory Evaluation of an Experimental Fluoride Dentifrice Formulation Using an in Situ Remineralization/Fluoride Uptake Model

GlaxoSmithKline·interventional·Posted Sep 15, 2008·Updated Dec 8, 2016

In Brief

A Phase 2 clinical trial evaluating NaF/ KNO3/isopentane Dentifrice, NaF/KNO3 Dentifrice, and 2 other interventions for Dental Erosion. Completed, enrolled 20 participants.

Detailed Summary

The purpose of this study is to determine whether an experimental fluoridated dentifrice is effective in the treatment of dental caries

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDental Erosion
Countries--
Collaborators--

Timeline

Phase 2CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 15, 2008
Enrollment StartSep 1, 2007
Primary CompletionJan 1, 2008
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 17.8 years ago

Interventions

NaF/ KNO3/isopentane Dentifricedrug

Experimental toothpaste

NaF/KNO3 Dentifricedrug

Experimental toothpaste

NaF Dentifricedrug

Active comparator

Placebo Dentifriceother

Placebo comparator